Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Pittsburgh jury finds synagogue gunman eligible for the death penalty, setting up trial’s final phase

Jurors seemed to be unmoved by his lawyers’ arguments that his virulent antisemitism was delusional

PITTSBURGH (JTA) — Jurors in the trial of the gunman who killed 11 Jewish worshipers in a Pittsburgh synagogue took less than two hours to find him eligible for the death penalty, setting up a final phase of the historic proceedings in which the gunman may be sentenced to death. 

On Thursday morning, the seven women and five men on the jury unanimously found that Robert Bowers, who attacked the Tree of Life building on Oct. 27, 2018, met all four thresholds of intent necessary for capital punishment. The jurors also agreed with the government’s case that the crime carried four aggravating factors that exacerbated the shooter’s capital offenses. They were seemingly unmoved by the defense’s argument that the shooter’s antisemitism was a product of his delusion. 

On June 16, the jury found the defendant guilty of 63 crimes, including 22 capital crimes — two for each fatality.

The final phase of the trial will begin on Monday. In that portion, the jury will decide whether to deliver a sentence of death or life imprisonment without possibility of release.

In that phase, the jury will hear impact statements from some family members of the 11 people murdered by the gunman. Jurors will also hear from people who were injured or otherwise affected. Prosecutors said they expected to bring seven witnesses over two to three days.

The defense will then bring witnesses to prove mitigating factors, which lawyers said they expected to last five to seven days. Those witnesses are expected to describe the hardships the gunman suffered over his lifetime.

The alacrity of the verdict — jurors met for about an hour after closing arguments on Wednesday, and less than an hour on Thursday morning — suggests they summarily rejected arguments advanced by the defense that the gunman’s antisemitism was a sign that he was delusional.

Expert psychiatric witnesses for both sides who interviewed the shooter recently say he has no regrets, and the defense sought to use that fact to bolster its medical arguments that he was schizophrenic and did not have the intent to kill required for a death sentence.

This article originally appeared on JTA.org.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse..

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.